Early Outcomes of Intravitreal Aflibercept 8 mg in Eyes Previously Treated with Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration with AI-Based Biomarker Quantification.
Saved in:
| Title: | Early Outcomes of Intravitreal Aflibercept 8 mg in Eyes Previously Treated with Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration with AI-Based Biomarker Quantification. |
|---|---|
| Authors: | Bartolomeo, Nicolò1 (AUTHOR), Kalyvianakis, Konstantinos Kitsos1 (AUTHOR), Schuetz, Yannic Pannatier1 (AUTHOR), Nascimbeni, Anna Chiara1 (AUTHOR), Castro, Daniela Gallo1 (AUTHOR), Crozat, Baptiste1 (AUTHOR), Barry, Mamadou Pathé1 (AUTHOR), Ambresin, Aude1 (AUTHOR) aambresinsvrrc@swissvisio.net |
| Source: | Ophthalmology & Therapy. Feb2026, Vol. 15 Issue 2, p831-842. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938245 |
|---|---|
| DOI: | 10.1007/s40123-026-01320-5 |
